Annual accounts receivable:
$121.80M+$48.41M(+65.96%)Summary
- As of today (September 16, 2025), RARE annual accounts receivable is $121.80 million, with the most recent change of +$48.41 million (+65.96%) on December 31, 2024.
- During the last 3 years, RARE annual accounts receivable has risen by +$93.37 million (+328.39%).
- RARE annual accounts receivable is now at all-time high.
Performance
RARE Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$124.46M+$25.63M(+25.93%)Summary
- As of today (September 16, 2025), RARE quarterly accounts receivable is $124.46 million, with the most recent change of +$25.63 million (+25.93%) on June 30, 2025.
- Over the past year, RARE quarterly accounts receivable has increased by +$18.48 million (+17.44%).
- RARE quarterly accounts receivable is now at all-time high.
Performance
RARE Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RARE Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +66.0% | +17.4% |
| 3 y3 years | +328.4% | +234.5% |
| 5 y5 years | +270.9% | +735.7% |
RARE Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +328.4% | at high | +299.4% |
| 5 y | 5-year | at high | +328.4% | at high | +735.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
RARE Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $124.46M(+25.9%) |
| Mar 2025 | - | $98.84M(-18.9%) |
| Dec 2024 | $121.80M(+66.0%) | $121.80M(+30.5%) |
| Sep 2024 | - | $93.30M(-12.0%) |
| Jun 2024 | - | $105.98M(+5.7%) |
| Mar 2024 | - | $100.25M(+36.6%) |
| Dec 2023 | $73.39M(+81.5%) | $73.39M(-7.4%) |
| Sep 2023 | - | $79.26M(+12.4%) |
| Jun 2023 | - | $70.52M(+64.0%) |
| Mar 2023 | - | $42.99M(+6.3%) |
| Dec 2022 | $40.45M(+42.3%) | $40.45M(+29.8%) |
| Sep 2022 | - | $31.16M(-16.2%) |
| Jun 2022 | - | $37.21M(+31.2%) |
| Mar 2022 | - | $28.37M(-0.2%) |
| Dec 2021 | $28.43M | $28.43M(+12.0%) |
| Sep 2021 | - | $25.38M(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $24.72M(-1.2%) |
| Mar 2021 | - | $25.03M(-49.0%) |
| Dec 2020 | $49.09M(+49.5%) | $49.09M(+76.8%) |
| Sep 2020 | - | $27.76M(+86.4%) |
| Jun 2020 | - | $14.89M(-49.2%) |
| Mar 2020 | - | $29.33M(-10.7%) |
| Dec 2019 | $32.84M(+157.8%) | $32.84M(+42.1%) |
| Sep 2019 | - | $23.12M(+10.6%) |
| Jun 2019 | - | $20.90M(+33.7%) |
| Mar 2019 | - | $15.63M(+22.7%) |
| Dec 2018 | $12.74M(+146.3%) | $12.74M(+39.2%) |
| Sep 2018 | - | $9.15M(-47.5%) |
| Jun 2018 | - | $17.43M(+374.7%) |
| Mar 2018 | - | $3.67M(-29.0%) |
| Dec 2017 | $5.17M(>+9900.0%) | $5.17M(>+9900.0%) |
| Dec 2016 | $0.00 | $0.00(-100.0%) |
| Sep 2013 | - | $38.00K |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual accounts receivable year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly accounts receivable year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual accounts receivable?
The current annual accounts receivable of RARE is $121.80M
What is the all time high annual accounts receivable for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual accounts receivable is $121.80M
What is Ultragenyx Pharmaceutical Inc. annual accounts receivable year-on-year change?
Over the past year, RARE annual accounts receivable has changed by +$48.41M (+65.96%)
What is Ultragenyx Pharmaceutical Inc. quarterly accounts receivable?
The current quarterly accounts receivable of RARE is $124.46M
What is the all time high quarterly accounts receivable for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly accounts receivable is $124.46M
What is Ultragenyx Pharmaceutical Inc. quarterly accounts receivable year-on-year change?
Over the past year, RARE quarterly accounts receivable has changed by +$18.48M (+17.44%)